CN113272275A - 一种左乙拉西坦中间体的制备方法 - Google Patents
一种左乙拉西坦中间体的制备方法 Download PDFInfo
- Publication number
- CN113272275A CN113272275A CN202080008317.3A CN202080008317A CN113272275A CN 113272275 A CN113272275 A CN 113272275A CN 202080008317 A CN202080008317 A CN 202080008317A CN 113272275 A CN113272275 A CN 113272275A
- Authority
- CN
- China
- Prior art keywords
- oxo
- ethyl
- alpha
- acid
- acetic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims description 4
- 229960004002 levetiracetam Drugs 0.000 title description 10
- HPHUVLMMVZITSG-ZCFIWIBFSA-N levetiracetam Chemical compound CC[C@H](C(N)=O)N1CCCC1=O HPHUVLMMVZITSG-ZCFIWIBFSA-N 0.000 title 1
- IODGAONBTQRGGG-UHFFFAOYSA-N 2-(2-oxopyrrolidin-1-yl)butanoic acid Chemical compound CCC(C(O)=O)N1CCCC1=O IODGAONBTQRGGG-UHFFFAOYSA-N 0.000 claims abstract description 20
- 238000000034 method Methods 0.000 claims abstract description 15
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 30
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 22
- 238000001816 cooling Methods 0.000 claims description 12
- IODGAONBTQRGGG-ZCFIWIBFSA-N (2r)-2-(2-oxopyrrolidin-1-yl)butanoic acid Chemical compound CC[C@H](C(O)=O)N1CCCC1=O IODGAONBTQRGGG-ZCFIWIBFSA-N 0.000 claims description 10
- 238000003756 stirring Methods 0.000 claims description 9
- IODGAONBTQRGGG-LURJTMIESA-N Levetiracetam acid Chemical compound CC[C@@H](C(O)=O)N1CCCC1=O IODGAONBTQRGGG-LURJTMIESA-N 0.000 claims description 8
- 238000010438 heat treatment Methods 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 6
- 239000000243 solution Substances 0.000 claims description 6
- 239000003513 alkali Substances 0.000 claims description 5
- 239000002585 base Substances 0.000 claims description 5
- 238000004321 preservation Methods 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 4
- 229910052799 carbon Inorganic materials 0.000 claims description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 3
- 239000007864 aqueous solution Substances 0.000 claims description 2
- 238000010790 dilution Methods 0.000 claims description 2
- 239000012895 dilution Substances 0.000 claims description 2
- 238000001179 sorption measurement Methods 0.000 claims description 2
- HPHUVLMMVZITSG-LURJTMIESA-N levetiracetam Chemical compound CC[C@@H](C(N)=O)N1CCCC1=O HPHUVLMMVZITSG-LURJTMIESA-N 0.000 description 10
- 235000011121 sodium hydroxide Nutrition 0.000 description 9
- 239000012535 impurity Substances 0.000 description 7
- 239000012452 mother liquor Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 239000007788 liquid Substances 0.000 description 4
- 238000005303 weighing Methods 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 3
- 239000003651 drinking water Substances 0.000 description 3
- 235000020188 drinking water Nutrition 0.000 description 3
- 230000006340 racemization Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000000967 suction filtration Methods 0.000 description 2
- -1 acetylpyrrolidine compound Chemical class 0.000 description 1
- 238000005915 ammonolysis reaction Methods 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 229960003965 antiepileptics Drugs 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- NLFBCYMMUAKCPC-KQQUZDAGSA-N ethyl (e)-3-[3-amino-2-cyano-1-[(e)-3-ethoxy-3-oxoprop-1-enyl]sulfanyl-3-oxoprop-1-enyl]sulfanylprop-2-enoate Chemical compound CCOC(=O)\C=C\SC(=C(C#N)C(N)=O)S\C=C\C(=O)OCC NLFBCYMMUAKCPC-KQQUZDAGSA-N 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 229940062717 keppra Drugs 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000000197 pyrolysis Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
- C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pyrrole Compounds (AREA)
Abstract
本申请提供了一种通过消旋回收获得高质量的(RS)‑α‑乙基‑2‑氧代‑1‑吡咯烷乙酸,本申请提供的方法可以显著提高消旋回收产品(RS)‑α‑乙基‑2‑氧代‑1‑吡咯烷乙酸的质量和外观,且对产品收率无影响。
Description
PCT国内申请,说明书已公开。
Claims (6)
- PCT国内申请,权利要求书已公开。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2019103284629 | 2019-04-23 | ||
CN201910328462.9A CN110003074A (zh) | 2019-04-23 | 2019-04-23 | 一种左乙拉西坦中间体的制备方法 |
PCT/CN2020/085370 WO2020216146A1 (zh) | 2019-04-23 | 2020-04-17 | 一种左乙拉西坦中间体的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113272275A true CN113272275A (zh) | 2021-08-17 |
CN113272275B CN113272275B (zh) | 2024-01-12 |
Family
ID=67173668
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910328462.9A Pending CN110003074A (zh) | 2019-04-23 | 2019-04-23 | 一种左乙拉西坦中间体的制备方法 |
CN202080008317.3A Active CN113272275B (zh) | 2019-04-23 | 2020-04-17 | 一种左乙拉西坦中间体的制备方法 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910328462.9A Pending CN110003074A (zh) | 2019-04-23 | 2019-04-23 | 一种左乙拉西坦中间体的制备方法 |
Country Status (4)
Country | Link |
---|---|
US (1) | US20220162165A1 (zh) |
EP (1) | EP3960732A4 (zh) |
CN (2) | CN110003074A (zh) |
WO (1) | WO2020216146A1 (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110003074A (zh) * | 2019-04-23 | 2019-07-12 | 浙江华海药业股份有限公司 | 一种左乙拉西坦中间体的制备方法 |
US11384050B1 (en) | 2021-02-03 | 2022-07-12 | Vitaworks Ip, Llc | Method for preparing levetiracetam and intermediates thereof |
CN114702426A (zh) * | 2022-05-24 | 2022-07-05 | 雅本化学股份有限公司 | 一种左乙拉西坦中间体的合成方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006053441A1 (en) * | 2004-11-22 | 2006-05-26 | Apotex Pharmachem Inc. | Improved process for the preparation of (s)-alpha-etyl-2-oxo-1-pyrrolidineacetamide and (r)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide |
CN101333180A (zh) * | 2007-06-29 | 2008-12-31 | 浙江华海药业股份有限公司 | 一种制备左乙拉西坦中间体的方法 |
CN108707099A (zh) * | 2018-06-19 | 2018-10-26 | 浙江华海药业股份有限公司 | 一种左乙拉西坦中间体的制备方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8412357D0 (en) | 1984-05-15 | 1984-06-20 | Ucb Sa | Pharmaceutical composition |
IN2005MU01546A (zh) * | 2005-12-13 | 2007-08-24 | M.M.V. Ramana | |
CN101838211B (zh) * | 2009-03-16 | 2014-07-02 | 黄冈华阳药业有限公司 | 生产左乙拉西坦的中间体2-氨基丁酸的工艺方法 |
CN104370791B (zh) * | 2014-11-28 | 2018-09-21 | 上虞京新药业有限公司 | 一种左乙拉西坦的纯化方法 |
CN110003074A (zh) * | 2019-04-23 | 2019-07-12 | 浙江华海药业股份有限公司 | 一种左乙拉西坦中间体的制备方法 |
-
2019
- 2019-04-23 CN CN201910328462.9A patent/CN110003074A/zh active Pending
-
2020
- 2020-04-17 CN CN202080008317.3A patent/CN113272275B/zh active Active
- 2020-04-17 WO PCT/CN2020/085370 patent/WO2020216146A1/zh unknown
- 2020-04-17 US US17/600,535 patent/US20220162165A1/en active Pending
- 2020-04-17 EP EP20795993.3A patent/EP3960732A4/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006053441A1 (en) * | 2004-11-22 | 2006-05-26 | Apotex Pharmachem Inc. | Improved process for the preparation of (s)-alpha-etyl-2-oxo-1-pyrrolidineacetamide and (r)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide |
CN101333180A (zh) * | 2007-06-29 | 2008-12-31 | 浙江华海药业股份有限公司 | 一种制备左乙拉西坦中间体的方法 |
CN108707099A (zh) * | 2018-06-19 | 2018-10-26 | 浙江华海药业股份有限公司 | 一种左乙拉西坦中间体的制备方法 |
Non-Patent Citations (1)
Title |
---|
刘晓光;张存莉;王九;吴阳;杨秋燕;王俊臣;: "左乙拉西坦中间体LV30结晶母液回收的研究", 山东化工, no. 16, pages 29 * |
Also Published As
Publication number | Publication date |
---|---|
CN113272275B (zh) | 2024-01-12 |
WO2020216146A1 (zh) | 2020-10-29 |
EP3960732A1 (en) | 2022-03-02 |
US20220162165A1 (en) | 2022-05-26 |
CN110003074A (zh) | 2019-07-12 |
EP3960732A4 (en) | 2022-07-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN113272275A (zh) | 一种左乙拉西坦中间体的制备方法 | |
Bailey et al. | The Mannich Reaction with 1, 2-Dibenzoylethane1, 2 | |
CN115505622A (zh) | 制3α,7β-二羟基-5α-H的UDCA异构体方法 | |
CN102382050A (zh) | 一种取代的1,2,3,4-四氢喹啉-4-酮盐酸盐的制备方法 | |
JPH082903B2 (ja) | 醗酵法で製造されたリボフラビンの精製法 | |
CN104262208A (zh) | 一种联产邻磺酸钠苯甲醛和邻氯苯甲酸的方法 | |
US4111980A (en) | Process for preparing optically active phenyl glycine | |
CN109836344B (zh) | 一种有机溶剂生产甘氨酸的方法 | |
CN111484463A (zh) | 一种泛醇母液回收利用方法 | |
CN101759582A (zh) | Dl-对羟基苯甘氨酸生产新工艺 | |
CN112661719B (zh) | 一种氨噻肟酸的清洁制备工艺 | |
US3147302A (en) | Separation of glutamic acid from a fermented liquor | |
US2031666A (en) | Production of 5-halogen-2-aminotoluenes | |
RU2234492C1 (ru) | Способ получения 2,3,4-триметоксибензальдегида | |
JPH04360863A (ja) | N−アルキルアミノエタンスルホン酸ナトリウムの製造方法 | |
CN110845354B (zh) | 一种西司他丁钠中间体的制备方法 | |
SU1159919A1 (ru) | Способ получени 5-аминосалициловой кислоты | |
SU1051057A1 (ru) | Способ очистки п-крезола | |
SU372201A1 (ru) | Способ выделения хлорзамещенных фенолов | |
CN107674046B (zh) | 一种阿扎那韦环氧化物中间体的纯化方法 | |
SU1133260A1 (ru) | Способ получени моноацетата цис-1,2-аценафтандиола | |
SU108897A1 (ru) | Способ получени 4-нитрозо-5-нитро--1-нафтола | |
SU401139A1 (ru) | Способ получени -/2-ацетил-4-хлор-феноксиэтил- , диметил- -бензиламмоний -хлорбензолсульфоната | |
SU1159920A1 (ru) | Способ получени 2-(2-окси-5-метилфенил)- @ -бензтриазола | |
CN116462682A (zh) | 一种托法替尼脱甲基杂质的合成方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |